Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377014725> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4377014725 endingPage "S673" @default.
- W4377014725 startingPage "S673" @default.
- W4377014725 abstract "Persistence of orthostatic tachycardia, palpitations, and fatigue beyond 4 weeks of an acute COVID-19 infection has been termed Post-Acute Sequelae of COVID-19 (PASC) POTS. We have previously reported 6-month outcomes of PASC POTS. Long-term management and outcomes of these patients is unknown. To examine the long-term management and outcomes of PASC POTS patients. We conducted a retrospective study of all patients who were diagnosed with POTS at Cardiology, Neurology, and Rehabilitation Post-COVID clinic after a COVID-19 infection between March 1, 2020, and November 1, 2022, at the University of Texas Health San Antonio. We examined COVID history, POTS diagnosis, management, and one-year outcomes of post-COVID POTS patients. In 42 patients that were diagnosed with PASC POTS, 33 had a one-year follow-up. 100% were female, 60.6% were Caucasian. Average age was 40.6 + 11 years while the average BMI was 31.9 + 10.4 kg/m2. The most common symptoms were fatigue (87.9%), palpitations (75.7%), brain fog (72.7%), orthostatic tachycardia, exercise intolerance, and dyspnea (70%). The mean heart rate change with 10-minute standing test was 42.68 + 26.73 beats per minute. At 12-months follow-up, the most common symptom was still fatigue (66.7%), palpitations (45.5%), orthostatic tachycardia, and orthostatic intolerance (42.4%). All patients were managed with increased salt and fluid intake, lower compression stockings and rehabilitation. Fifty five percent of patients were treated with Enhanced External Counter Pulsation (EECP), 42% were treated with beta blockers, 18% with fludrocortisone, 15% with midodrine, and 15% with Pyridostigmine. At 1 year follow-up, 33% of patients reported improvement in their symptoms, 33% reported worsening of symptoms, 24% reported stable symptoms, and 9% had resolution. PASC POTS patients continue to experience adverse symptoms even at one year. Physical therapy and rehabilitation and pharmacological therapy appear improve symptoms in a minority of patients." @default.
- W4377014725 created "2023-05-19" @default.
- W4377014725 creator A5015148169 @default.
- W4377014725 creator A5032545533 @default.
- W4377014725 creator A5046225491 @default.
- W4377014725 creator A5053545658 @default.
- W4377014725 creator A5059748441 @default.
- W4377014725 creator A5067505792 @default.
- W4377014725 creator A5074552016 @default.
- W4377014725 date "2023-05-01" @default.
- W4377014725 modified "2023-10-17" @default.
- W4377014725 title "PO-05-201 ONE-YEAR LONG-TERM FOLLOW UP FOR POST-ACUTE SEQUELAE OF COVID-19 POTS PATIENTS" @default.
- W4377014725 doi "https://doi.org/10.1016/j.hrthm.2023.03.1404" @default.
- W4377014725 hasPublicationYear "2023" @default.
- W4377014725 type Work @default.
- W4377014725 citedByCount "0" @default.
- W4377014725 crossrefType "journal-article" @default.
- W4377014725 hasAuthorship W4377014725A5015148169 @default.
- W4377014725 hasAuthorship W4377014725A5032545533 @default.
- W4377014725 hasAuthorship W4377014725A5046225491 @default.
- W4377014725 hasAuthorship W4377014725A5053545658 @default.
- W4377014725 hasAuthorship W4377014725A5059748441 @default.
- W4377014725 hasAuthorship W4377014725A5067505792 @default.
- W4377014725 hasAuthorship W4377014725A5074552016 @default.
- W4377014725 hasBestOaLocation W43770147251 @default.
- W4377014725 hasConcept C126322002 @default.
- W4377014725 hasConcept C164705383 @default.
- W4377014725 hasConcept C2776403943 @default.
- W4377014725 hasConcept C2779134260 @default.
- W4377014725 hasConcept C2779624417 @default.
- W4377014725 hasConcept C2780283014 @default.
- W4377014725 hasConcept C2910439992 @default.
- W4377014725 hasConcept C3008058167 @default.
- W4377014725 hasConcept C524204448 @default.
- W4377014725 hasConcept C71924100 @default.
- W4377014725 hasConcept C73787029 @default.
- W4377014725 hasConcept C84393581 @default.
- W4377014725 hasConceptScore W4377014725C126322002 @default.
- W4377014725 hasConceptScore W4377014725C164705383 @default.
- W4377014725 hasConceptScore W4377014725C2776403943 @default.
- W4377014725 hasConceptScore W4377014725C2779134260 @default.
- W4377014725 hasConceptScore W4377014725C2779624417 @default.
- W4377014725 hasConceptScore W4377014725C2780283014 @default.
- W4377014725 hasConceptScore W4377014725C2910439992 @default.
- W4377014725 hasConceptScore W4377014725C3008058167 @default.
- W4377014725 hasConceptScore W4377014725C524204448 @default.
- W4377014725 hasConceptScore W4377014725C71924100 @default.
- W4377014725 hasConceptScore W4377014725C73787029 @default.
- W4377014725 hasConceptScore W4377014725C84393581 @default.
- W4377014725 hasIssue "5" @default.
- W4377014725 hasLocation W43770147251 @default.
- W4377014725 hasLocation W43770147252 @default.
- W4377014725 hasOpenAccess W4377014725 @default.
- W4377014725 hasPrimaryLocation W43770147251 @default.
- W4377014725 hasRelatedWork W1506125406 @default.
- W4377014725 hasRelatedWork W2016827634 @default.
- W4377014725 hasRelatedWork W2071226736 @default.
- W4377014725 hasRelatedWork W2152830608 @default.
- W4377014725 hasRelatedWork W2400564914 @default.
- W4377014725 hasRelatedWork W2516786600 @default.
- W4377014725 hasRelatedWork W2986032008 @default.
- W4377014725 hasRelatedWork W2996476724 @default.
- W4377014725 hasRelatedWork W4289539078 @default.
- W4377014725 hasRelatedWork W4377014725 @default.
- W4377014725 hasVolume "20" @default.
- W4377014725 isParatext "false" @default.
- W4377014725 isRetracted "false" @default.
- W4377014725 workType "article" @default.